Current Research Pipeline
| Project | Stage | Comment |
|---|---|---|
| LF001 | Clinical Stage III | Novel treatment for hereditary blood diseases. Successful conclusion of the MemSID trial at the University Hospital of Zurich. Patents granted (USPO, EPA, CH). Follow-up trial in Afula, israel with adolescent patients and escalated patient numbers concluded. Preparation for a clinical phase III trial. |
| LF002 | Proof-of-Concept | Novel diagnostic method for assessing human blood quality. |
| LF003 | Proof-of-Concept | Novel method for improved blood storage. |
| LF006 | Entered Clinical Trials | Novel treatment for horse heart arrhythmia. |
Taking initiative
Lyfjos® is actively perusing trends in the industry and is committed building a promising and robust in-house product pipeline. Lyfjos® is focused on projects that have direct application with the desired product in mind. In this sense, we are using our in-depth knowledge in the specific areas for collecting the low hanging fruits.
In most cases, the desired product out of an invention is not directly linked to the basic research that is being conducted by scientists. Lyfjos® provides these links.
RESEARCHERS
- Ways to secure funding for specific projects.
- Project management
- Assessing current discoveries
- Translating discoveries into a products
- Strategies to commercialize a product
INDUSTRY
- Chances for optimizing and extending the current product pipeline.
- Collaboration possibilities within international academic frameworks
- Assessing current discoveries
- Technology transfer
INVESTORS
- Ways to secure funding for specific projects.
- Ways to secure funding for specific projects.
- Project management
- Assessing current discoveries
- Translating discoveries into a products
- Strategies to commercialize a product